Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Safety and efficacy of B-cell depletion with rituximab for the treatment of systemic sclerosis–associated pulmonary arterial hypertension: A multicenter, double-blind, randomized, placebo-controlled trial
NIH ASC01 Study Group, Jul 15 2021, In: American journal of respiratory and critical care medicine. 204, 2, p. 209-221 13 p.Research output: Contribution to journal › Article › peer-review
31 Scopus citations -
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Khanna, D., Spino, C., Johnson, S., Chung, L., Whitfield, M. L., Denton, C. P., Berrocal, V., Franks, J., Mehta, B., Molitor, J., Steen, V. D., Lafyatis, R., Simms, R. W., Gill, A., Kafaja, S., Frech, T. M., Hsu, V., Domsic, R. T., Pope, J. E., Gordon, J. K. & 19 others, , Jan 1 2020, In: Arthritis and Rheumatology. 72, 1, p. 125-136 12 p.Research output: Contribution to journal › Article › peer-review
88 Scopus citations -
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial
Chung, L., Spino, C., McLain, R., Johnson, S. R., Denton, C. P., Molitor, J. A., Steen, V. D., Lafyatis, R., Simms, R. W., Kafaja, S., Frech, T. M., Hsu, V., Domsic, R. T., Pope, J. E., Gordon, J. K., Mayes, M. D., Sandorfi, N., Hant, F. N., Bernstein, E. J., Chatterjee, S. & 12 others, , Dec 2020, In: The Lancet Rheumatology. 2, 12, p. e743-e753Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the pharos registry
Hsu, V. M., Chung, L., Hummers, L. K., Shah, A., Simms, R., Bolster, M., Hant, F. N., Silver, R. M., Fischer, A., Hinchcliff, M. E., Varga, J., Goldberg, A. Z., Derk, C. T., Schiopu, E., Khanna, D., Shapiro, L. S., Domsic, R. T., Medsger, T., Mayes, M. D., Furst, D. & 5 others, , Feb 1 2019, In: Journal of Rheumatology. 46, 2, p. 176-183 8 p.Research output: Contribution to journal › Article › peer-review
13 Scopus citations -
Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials
Participants in the Scleroderma Lung Study I and members of the Scleroderma Lung Study II Research Group, Mar 2018, In: Arthritis Care and Research. 70, 3, p. 439-444 6 p.Research output: Contribution to journal › Article › peer-review
Open Access39 Scopus citations